Reactivation of tuberculosis in hepatocellular carcinoma treated with transcatheter arterial chemoembolization: A report of 3 cases

被引：3

作者：

Yun Jeung Kim ^{[1
]}

Pyung Gohn Goh ^{[1
]}

Hee Seok Moon ^{[1
]}

Eaum Seok Lee ^{[1
]}

Seok Hyun Kim ^{[1
]}

Byung Seok Lee ^{[1
]}

Heon Young Lee ^{[1
]}

机构：

[1] Division of Hepatology, Department of Internal Medicine, Chung-Nam National University Hospital, 640 Daesa-Dong, Jung-Gu, Daejeon 301-721, South Korea

来源：

World Journal of Radiology | 2012年 / 05期

关键词：

Hepatocellular carcinoma; Reactivation; Transcatheter arterial chemoembolization; Tuberculosis;

D O I：

暂无

中图分类号：

R735.7 [肝肿瘤];

学科分类号：

100214 ;

摘要：

Pulmonary tuberculosis is an opportunistic infection that can be reactivated in immunocompromised conditions, for example, in malignancy or after liver transplantation. Hepatocellular carcinoma (HCC) has a high mortality rate because it is frequently diagnosed at an advanced stage. Although surgical resection is the established curative measure for HCC, it is only feasible for earlystage HCC. Transcatheter arterial chemoembolization (TACE) is the most common treatment modality for patients with unresectable HCC. However, repeated TACE sessions and, occasionally, the tumor itself can further impair the reserve hepatic function and immunity. We report 3 recent cases of HCC with reactivation of pulmonary tuberculosis after TACE.

引用

页码：236 / 240

页数：5

共 7 条

[1] Ruptured hepatocellular carcinoma following chemoembolization:a western experience [J].

Narendra Battula ;

Parthi Srinivasan ;

Mansoor Madanur ;

Srinivas Prabhu Chava ;

Oliver Priest ;

Mohamed Rela ;

Nigel Heaton .

Hepatobiliary&PancreaticDiseasesInternational, 2007, (01) :49-51

[2] Comparison of Conventional Transarterial Chemoembolization (TACE) and Chemoembolization With Doxorubicin Drug Eluting Beads (DEB) for Unresectable Hepatocelluar Carcinoma (HCC) [J].

Dhanasekaran, Renumathy ;

Kooby, David A. ;

Staley, Charles A. ;

Kauh, John S. ;

Khanna, Vinit ;

Kim, Hyun S. .

JOURNAL OF SURGICAL ONCOLOGY, 2010, 101 (06) :476-480

[3]

Review article: the management of hepatocellular carcinoma[J] . R.CABRERA,D. R.NELSON. Alimentary Pharmacology & Therapeutics . 2010 (4)

[4] Treatment before liver transplantation for HCC [J].

Belghiti, J. ;

Carr, B. I. ;

Greig, P. D. ;

Lencioni, R. ;

Poon, R. T. .

ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (04) :993-1000

[5] Mycobacterium tuberculosis infection following renal transplantation in Taiwan [J].

Chen, C. -H. ;

Lian, J. -D. ;

Cheng, C. -H. ;

Wu, M. -J. ;

Lee, W. -C. ;

Shu, K. -H. .

TRANSPLANT INFECTIOUS DISEASE, 2006, 8 (03) :148-156

[6]

Transcatheter Arterial Chemoembolization Therapy for Patients With Hepatocellular Carcinoma: A Case-Controlled Study[J] . Maurizio Biselli,Pietro Andreone,Annagiulia Gramenzi,Franco Trevisani,Carmela Cursaro,Cristina Rossi,Salvatore Ricca Rosellini,Carlo Cammà,Stefania Lorenzini,Giuseppe Francesco Stefanini,Giovanni Gasbarrini,Mauro Bernardi. Clinical Gastroenterology and Hepatology . 2005 (9)

[7] Updated treatment approach to hepatocellular carcinoma [J].

Llovet, JM .

JOURNAL OF GASTROENTEROLOGY, 2005, 40 (03) :225-235

← 1 →